Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (251-260 of 284) with videos related to

Pageof 29
Sort By:
Pathologie-Biologie|June 24, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]S Nguyen, D Blaise, J-O Bay, et al.
Bone Marrow Transplantation|February 11, 2014
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphomaI Avivi, C Canals, J-P Vernant, et al.
Bone Marrow Transplantation|May 4, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphomaL Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation|January 17, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphomaL Castagna, S Bramanti, R Devillier, et al.
Leukemia|May 17, 2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantationM Mohty, K Bilger, E Jourdan, et al.
Bone Marrow Transplantation|December 1, 2015
Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working PartyS P Robinson, A Boumendil, H Finel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 24, 2019
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, M Labopin, M Christopeit, et al.
Bone Marrow Transplantation|July 10, 2012
The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMTS Giebel, M Labopin, M Mohty, et al.
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Leukemia|November 28, 2006
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemiaA-L Herr, M Labopin, D Blaise, et al.
Pageof 29

Showing results (251-260 of 284) with videos related to

Sort By:
Pageof 29
Pathologie-Biologie|June 24, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]S Nguyen, D Blaise, J-O Bay, et al.
Bone Marrow Transplantation|February 11, 2014
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphomaI Avivi, C Canals, J-P Vernant, et al.
Bone Marrow Transplantation|May 4, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphomaL Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation|January 17, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphomaL Castagna, S Bramanti, R Devillier, et al.
Leukemia|May 17, 2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantationM Mohty, K Bilger, E Jourdan, et al.
Bone Marrow Transplantation|December 1, 2015
Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working PartyS P Robinson, A Boumendil, H Finel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 24, 2019
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, M Labopin, M Christopeit, et al.
Bone Marrow Transplantation|July 10, 2012
The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMTS Giebel, M Labopin, M Mohty, et al.
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Leukemia|November 28, 2006
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemiaA-L Herr, M Labopin, D Blaise, et al.
Pageof 29